cbdMD, Inc. Earnings Per Share Disclosure
NOTE 14 – LOSS PER SHARE
The following table sets forth the computation of basic and diluted loss per share for the following periods:
| Year Ended | ||||||||
| September 30, | September 30, | |||||||
| 2025 | 2024 | |||||||
| Basic: | ||||||||
| Net loss | $ | (2,040,902 | ) | $ | (3,700,126 | ) | ||
| Preferred dividends paid or accrued | 2,334,501 | 4,004,001 | ||||||
| Net income loss attributable to cbdMD Inc. common shareholders | (4,375,403 | ) | (7,704,127 | ) | ||||
| Shares used in computing basic earnings per share | 4,022,629 | 539,069 | ||||||
| Shares used in computing diluted earnings per share | 4,022,629 | 539,069 | ||||||
| Earnings per share Basic: | - | |||||||
| Basic earnings per share | (1.09 | ) | (14.29 | ) | ||||
| Earnings per share Diluted: | ||||||||
| Diluted earnings per share | (1.09 | ) | (14.29 | ) | ||||
At the year ended September 30, 2025, 100,993 potential shares underlying options, unvested RSUs and warrants as well as 1.7 million shares issuable upon conversion of our Series B Preferred stock which are excluded from the shares used to calculate diluted loss per share as their inclusion would reduce net loss per share.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Dec 19, 2025 | Showing above |
| 2024 | Dec 18, 2024 | |
| 2023 | Dec 22, 2023 | |
| 2022 | Dec 15, 2022 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.